Cannabinoids for Tourette’s Syndrome.

Authors: Adrienne Curtis, Carl E Clarke, Hugh E Rickards
Cochrane Database of Systematic Reviews, 7 October 2009

BACKGROUND: Gilles de la Tourette Syndrome (GTS) is a developmental neuropsychiatric disorder characterised by the presence of chronic motor and phonic tics. Drugs currently used in the treatment of GTS either lack efficacy or are associated with intolerable side effects. Ther…